Hillsdale Investment Management Inc. Meridian Bioscience Inc Transaction History

Hillsdale Investment Management Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 21, 2021	SELL	$17.35 - $22.5 $2.39 Million - $3.1 Million	-137,900 Closed	0 $0
Q1 2021 Apr 22, 2021	SELL	$19.76 - $29.89 $922,792 - $1.4 Million	-46,700 Reduced 25.3%	137,900 $3.62 Million
Q4 2020 Feb 09, 2021	SELL	$15.73 - $21.66 $11,011 - $15,162	-700 Reduced 0.38%	184,600 $3.45 Million
Q3 2020 Nov 13, 2020	BUY	$13.54 - $26.41 $2,708 - $5,282	200 Added 0.11%	185,300 $3.15 Million
Q2 2020 Aug 11, 2020	BUY	$7.84 - $23.29 $1.45 Million - $4.31 Million	185,100 New	185,100 $4.31 Million

113K

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

Get notified when there are updates to the investment portfolio of Hillsdale Investment Management Inc., based on Form 13F filings with the SEC.

Stay updated on Hillsdale Investment Management Inc. with notifications on news.